Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden · Delayed Price · Currency is SEK 273.00
+6.00 (2.25%)
Jun 12, 2026, 5:29 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 8.6 billion as of June 12, 2026. Its market cap has decreased by -14.10% in one year.
Market Cap
8.60B
Enterprise Value
8.41B
Revenue
834.53M
Ranking
n/a
PE Ratio
116.52
Stock Price
273.00
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 8.60B, an increase of 2,213.57%. That is a compound annual growth rate of 25.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 8.60B | 46.30% |
| Dec 30, 2025 | 5.88B | -61.84% |
| Dec 30, 2024 | 15.40B | 48.41% |
| Dec 29, 2023 | 10.38B | 90.12% |
| Dec 30, 2022 | 5.46B | -33.55% |
| Dec 30, 2021 | 8.22B | -8.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sectra AB | 58.19B |
| Getinge AB | 53.45B |
| Elekta AB | 20.02B |
| Nolato AB | 13.19B |
| Vitrolife AB | 12.97B |
| MedCap AB | 7.47B |
| CellaVision AB | 3.30B |
| Devyser Diagnostics AB | 1.51B |